Commit To Purchase Sarepta Therapeutics At $18, Earn 16.7% Using Options
February 23, 2017 at 11:51 AM EST
Investors considering a purchase of Sarepta Therapeutics Inc (SRPT) stock, but tentative about paying the going market price of $29.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $18 strike, which has a bid at the time of this writing of $3.00..